/
PepGen Inc.
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.
Mentions
1 mention · latest on 29 Jul 2026
See which tracked investors hold PepGen Inc. →Ownership and position changes on OwnershipTrace